| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787497 | Journal of the Egyptian National Cancer Institute | 2017 | 6 Pages |
Abstract
KRT15 can be used to differentiate between circulating CD133+ cells from HCC group and control group. However, further study may be needed to confirm on the protein level.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Abdel-Rahman N. Zekri, Enas R. El-Sisi, Zeinab F. Abdallah, Alaa Ismail, Ahmed Barakat Barakat,